Zijun Zhen

618 total citations
62 papers, 389 citations indexed

About

Zijun Zhen is a scholar working on Neurology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Zijun Zhen has authored 62 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Neurology, 26 papers in Oncology and 18 papers in Pathology and Forensic Medicine. Recurrent topics in Zijun Zhen's work include Neuroblastoma Research and Treatments (27 papers), Lymphoma Diagnosis and Treatment (17 papers) and Lung Cancer Research Studies (9 papers). Zijun Zhen is often cited by papers focused on Neuroblastoma Research and Treatments (27 papers), Lymphoma Diagnosis and Treatment (17 papers) and Lung Cancer Research Studies (9 papers). Zijun Zhen collaborates with scholars based in China, United States and Canada. Zijun Zhen's co-authors include Jia Zhu, Junting Huang, Feifei Sun, Suying Lü, Yizhuo Zhang, You‐Jian He, Xiaofei Sun, Kai‐Bin Yang, Yue Cai and Yi Que and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Zijun Zhen

54 papers receiving 381 citations

Peers

Countries citing papers authored by Zijun Zhen

Since Specialization

Citations

This map shows the geographic impact of Zijun Zhen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zijun Zhen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zijun Zhen more than expected).

Fields of papers citing papers by Zijun Zhen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zijun Zhen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zijun Zhen. The network helps show where Zijun Zhen may publish in the future.

Co-authorship network of co-authors of Zijun Zhen

This figure shows the co-authorship network connecting the top 25 collaborators of Zijun Zhen. A scholar is included among the top collaborators of Zijun Zhen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zijun Zhen. Zijun Zhen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and efficacy of sintilimab versus pembrolizumab in the treatment of advanced or recurrent pediatric malignancies: a real-world study in China 2025 ·Frontiers in Immunology ·Lei Mao, Mengzhen Li, (unknown), Juan Wang, (unknown), Feifei Sun, (unknown), Suying Lü, Zijun Zhen, (unknown), Mengjia Song, Yizhuo Zhang	0
2	Safety and feasibility of anlotinib in children with high risk, recurrent or refractory sarcomas: an open-label, single-centre, single-arm, phase Ia/Ib trial 2025 ·EClinicalMedicine ·Suying Lü, Yi Que, Dongyang Liu, Feifei Sun, (unknown), Liting Deng, Jing Zhan, (unknown), (unknown), Xin Wang, (unknown), Zijun Zhen, Jia Zhu, Juan Wang, Yizhuo Zhang	1
3	Effect of body mass index on the prognosis of children and adolescents with high‐grade mature B‐cell non‐Hodgkin lymphoma 2024 ·Cancer ·(unknown), Zhiqing Wei, Junting Huang, Jia Zhu, Feifei Sun, Juan Wang, Suying Lü, Yizhuo Zhang, Xiaofei Sun, Zijun Zhen	0
4	MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma 2024 ·Cell Death and Disease ·(unknown), Mengzhen Li, Yi Wang, Yu Zhang, Yi Que, Suying Lü, (unknown), Jia Zhu, Junting Huang, Zijun Zhen, Feifei Sun, Mengjia Song, Yizhuo Zhang	7
5	Safety and clinical efficacy of sintilimab (anti-PD-1) in pediatric patients with advanced or recurrent malignancies in a phase I study 2023 ·Signal Transduction and Targeted Therapy ·Yi Que, Juan Wang, Feifei Sun, Shan Wang, Jia Zhu, Junting Huang, (unknown), Li Zhang, (unknown), (unknown), Zijun Zhen, Xiaofei Sun, Suying Lü, Yizhuo Zhang	5
6	Long‐term follow‐up results of pediatric and adolescent patients with localized Ewing sarcoma treated based on stratified modalities 2023 ·Cancer Medicine ·(unknown), Tingting Chen, Juan Wang, Feifei Sun, Junting Huang, Suying Lü, Jia Zhu, Yizhuo Zhang, Xiaofei Sun, Zijun Zhen	1
7	Vincristine and dexamethasone pulses in addition to maintenance therapy among pediatric acute lymphoblastic leukemia (GD‐ALL‐2008): An open‐label, multicentre, randomized, phase III clinical trial 2023 ·American Journal of Hematology ·(unknown), (unknown), Libin Huang, Changgang Li, (unknown), Riyang Liu, Huiqin Chen, Yongsheng Ruan, Zijun Zhen, Chi Kong Li, Jian‐Pei Fang	9
8	The dual HDAC and PI3K inhibitor, CUDC‑907, inhibits tumor growth and stem‑like properties by suppressing PTX3 in neuroblastoma 2023 ·International Journal of Oncology ·Mengzhen Li, Yang Hu, (unknown), Yanjie Xu, (unknown), Li Zhang, Qiuyun Luo, Zijun Zhen, Suying Lü, Junting Huang, Jia Zhu, Yizhuo Zhang, Yi Que, Feifei Sun	8
9	Phase I study of anlotinib in pediatric patients with high-risk, recurrent, or refractory sarcomas. 2023 ·Journal of Clinical Oncology ·Suying Lü, (unknown), Feifei Sun, Junting Huang, Jia Zhu, (unknown), Zijun Zhen, Yizhuo Zhang	1
10	Relationship between methylenetetrahydrofolate reductase gene polymorphisms and methotrexate drug metabolism and toxicity 2023 ·Translational Pediatrics ·(unknown), Qian Kong, Xinyu Li, Yan‐Lai Tang, Huirong Mai, Zijun Zhen, Dun‐hua Zhou, Huiqin Chen	12
11	Treatment outcomes for response-based radiotherapy in children and adolescents with central nervous system germinoma: a prospective study 2023 ·Journal of Neuro-Oncology ·(unknown), Qunying Yang, (unknown), Zhiqing Wei, Tingting Chen, Meiling Deng, Jian Wang, Juan Wang, Feifei Sun, Junting Huang, Suying Lü, Jia Zhu, Xiaofei Sun, Zijun Zhen	0
12	The Efficacy and Safety of Anlotinib in Pediatric Patients With Refractory or Recurrent Solid Tumors 2022 ·Frontiers in Pharmacology ·Suying Lü, (unknown), Huimou Chen, Liu-Hong Wu, Feifei Sun, Juan Wang, Jia Zhu, Yi Que, Lian Zhang, Zijun Zhen, Xiaofei Sun, Junting Huang, Yizhuo Zhang	4
13	KDM5B promotes tumorigenesis of Ewing sarcoma via FBXW7/CCNE1 axis 2022 ·Cell Death and Disease ·Binbin Chen, Huimou Chen, Suying Lü, Xiaoqin Zhu, Yi Que, Yu Zhang, Junting Huang, Li Zhang, (unknown), Feifei Sun, Juan Wang, Jia Zhu, Zijun Zhen, Yizhuo Zhang	22
14	Irinotecan Plus Doxorubicin Hydrochloride Liposomes for Relapsed or Refractory Wilms Tumor 2021 ·Frontiers in Oncology ·Juan Wang, Lian Zhang, (unknown), Yi Que, Yu Zhang, (unknown), Feifei Sun, Jia Zhu, Suying Lü, Junting Huang, Liu-Hong Wu, (unknown), Zijun Zhen, (unknown), (unknown), (unknown), (unknown)	4
15	Influence of MTHFR C677T and A1298C polymorphisms on the survival of pediatric patients with non-Hodgkin lymphoma 2021 ·Leukemia & lymphoma ·Xiaoqin Zhu, Wei Li, Jia Zhu, Huimou Chen, (unknown), Da‐Lei Zhou, Zijun Zhen, Feifei Sun, Junting Huang, (unknown), Xiaofei Sun, Suying Lü, Yizhuo Zhang	4
16	Influence of Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphism on High-Dose Methotrexate-Related Toxicities in Pediatric Non-Hodgkin Lymphoma Patients 2021 ·Frontiers in Oncology ·Suying Lü, Xiaoqin Zhu, Wei Li, Huimou Chen, Da‐Lei Zhou, Zijun Zhen, Feifei Sun, Junting Huang, Jia Zhu, Juan Wang, Yizhuo Zhang, Xiaofei Sun	10
17	Influence of UGT1A1 6/28 Polymorphisms on Irinotecan-Related Toxicity and Survival in Pediatric Patients with Relapsed/Refractory Solid Tumors Treated with the VIT Regimen 2021 ·Pharmacogenomics and Personalized Medicine ·Xiaoqin Zhu, Jia Zhu, Feifei Sun, Zijun Zhen, Da‐Lei Zhou, Suying Lü, Junting Huang, Yi Que, Lian Zhang, (unknown), Juan Wang, Yizhuo Zhang	3
18	<p>The Efficacy and Safety of Apatinib in Refractory/Relapse Advanced Pediatric Solid Tumor: A Retrospective Study</p> 2020 ·Cancer Management and Research ·Feifei Sun, Suying Lü, Zijun Zhen, Jia Zhu, Juan Wang, Junting Huang, Yu Zhang, Hui Li, (unknown), Meiling Liu, Liu-Hong Wu, (unknown), Yizhuo Zhang	1
19	Effect of excision extension of primary tumors on local control and survival of stage IV neuroblastoma 2014 ·Clinical Oncology and Cancer Research ·Pengfei Li, (unknown), Zijun Zhen, Zhuowei Liu, (unknown), Jia Zhu, Juan Wang, Suying Lü, Feifei Sun, Fei Zhang, (unknown), Xiaofang Guo, Xiaofei Sun	1
20	The value of primary site radiotherapy in stage IV high-risk neuroblastoma 2012 ·Zhonghua fangshe zhongliuxue zazhi ·(unknown), Zijun Zhen, Jia Zhu, Yan Chen, (unknown), Xiaofei Sun	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact